[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100578066":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":20,"centralContacts":24,"locations":29,"responsibleParty":44,"collaborators":19,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":50,"acronym":19,"eligibilityCriteria":51,"healthyVolunteers":48,"sex":52,"minAge":53,"maxAge":19,"enrollmentInfo":54,"targetDuration":19,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":63,"overallStatus":31,"whyStopped":19,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8],{"label":9,"type":6,"description":10,"interventionNames":11},"Bone metastasis","Patients with breast or lung or renal or gastroenteric tract or prostate carcinomas with bone metastases",[12],"Genetic: Biomolecular profile of bone metastases",[14],{"type":15,"name":16,"description":17,"armGroupLabels":18,"otherNames":19},"GENETIC","Biomolecular profile of bone metastases","Describe the biomolecular profile of bone metastases",[9],null,[21],{"name":22,"affiliation":5,"role":23},"Andrea Sambri, MD","PRINCIPAL_INVESTIGATOR",[25],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},"CONTACT","0512142680","andrea.sambri@aosp.bo.it",[30],{"facility":5,"status":31,"city":32,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"RECRUITING","Bologna","40138","Italy","IT",{"type":37,"coordinates":38},"Point",[39,40],11.33875,44.49381,{"lat":40,"lon":39},[43],{"name":22,"role":26,"phone":27,"phoneExt":19,"email":28},{"type":45,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100578066","biomolecular-markers-of-bone-metastasis-100578066",false,"NCT06806462","Biomolecular Markers of Bone Metastasis","Inclusion Criteria:\n\n* Age \\>= 18 years\n* Patients with breast or lung or renal or gastroenteric tract or prostate with bone metastases\n* Patients who knowingly express willingness to participate in the study after signing the written informed consent\n\nExclusion Criteria:\n\n* None","ALL","18 Years",{"count":55,"type":56},160,"ESTIMATED","INTERVENTIONAL",[59],"NA","The goal of this clinical trial is to characterize the biomolecular profile of bone metastases to define the predisposing profiles of bone metastasis, in patients with breast or lung or renal carcinomas or of the gastroenteric or prostate tract with bone metastasis.\n\nThe main question it aims to answer is:\n\nIs it possible to predict the progression of bone metastasis by identifying biomarkers as risk factors for bone metastasis?",[62],"Bone Metastasis",[64,65,66],"bone","metastasis","biomolecular profile","2025-01-28",{"date":69,"type":70},"2025-02-04","ACTUAL",{"date":72,"type":70},"2024-09-17",{"date":74,"type":56},"2026-09-17",{"name":5,"class":6},1]